BioUtah, the trade association, common voice, and flag bearer for Utah’s life sciences community, today announced that it will participate in the J.P. Morgan 44th Annual Healthcare Conference, January 11-16, 2026, in San Francisco. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the association, representing the more than 1,600 life sciences companies across the state. Utah boasts strengths in medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health.
BioUtah will also co-host an RSVP-required reception on Sunday night, January 11, 2026, at the start of the conference. Reach out to BioUtah if you would like to attend.
"Utah is one of the fastest growing innovation hubs in the nation, and we continue to be a hotbed for life sciences startups, supported by a uniquely collaborative ecosystem," said Cullimore. "The J.P. Morgan conference provides us with an extraordinary opportunity to spread the word about our culture of entrepreneurship, stellar research centers, educated workforce, business-friendly state, and the many Utah companies changing patients' lives.”
A number of Utah life sciences companies that are developing new treatments and cutting-edge medical technologies will be participating in the conference. Utah’s life sciences sector accounts for $22.6 billion in GDP and approximately 180,000 direct and indirect jobs.
Following the J.P. Morgan gathering, plan to attend the 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit, March 12-13, 2026, at the Hilton Hotel in Salt Lake City. Early bird registration is now open with discounts available through Feb. 15.
